This HTML5 document contains 47 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1097/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80450585
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у вересні 2004 article scientifique publié en 2004 artículu científicu espublizáu en setiembre de 2004 scientific article published on 01 September 2004 wetenschappelijk artikel im September 2004 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q80450585-81390238-5A27-4FB3-B36D-D427703D968A
wdt:P577
2004-09-01T00:00:00Z
p:P2093
wds:Q80450585-2B53D089-EECC-4590-B304-11AF9428CCEE wds:Q80450585-18066860-C718-458D-9E91-13C86F2D572B wds:Q80450585-C327D5DE-AC0A-4A68-A68B-A0AFBD31D79F
wdt:P2093
National Bacillus Calmette-Guerin/Interferon Phase 2 Investigator Group Christina Leopold Kathleen Lilli
rdfs:label
Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer
skos:prefLabel
Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer
schema:name
Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer
p:P50
wds:Q80450585-EA793787-AFD0-4851-8D46-3DB0D95DBFAC
wdt:P50
wd:Q71254368
p:P1476
wds:Q80450585-220C7525-637E-41E2-8E70-A589A9227838
wdt:P1476
Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer
p:P304
wds:Q80450585-596C12C4-DB54-43ED-B7CE-8BFDBCF3E0AF
wdt:P304
888-893
p:P31
wds:Q80450585-AD89B6E0-2623-4F86-952F-4035314FDE48
wdt:P31
wd:Q13442814
p:P921
wds:Q80450585-9BFC3EFF-B083-415F-A652-75218607D15B wds:Q80450585-6B75D3C9-BD26-4817-9364-C33E5B52BA36 wds:Q80450585-1042F511-87F7-42D9-8B56-79BAF31D709E
wdt:P921
wd:Q42824440 wd:Q6934595 wd:Q504775
p:P698
wds:Q80450585-7FCB458A-CB2B-4CF6-9155-13C07B915AF5
wdtn:P698
n10:15310991
wdt:P698
15310991
p:P1433
wds:Q80450585-392DD7A0-DB55-453B-93DF-C09BE66D3BB7
wdt:P1433
wd:Q15709979
p:P433
wds:Q80450585-855E32B0-1F6C-4DD8-81CD-C20FDD835EED
p:P478
wds:Q80450585-3C9920EE-7D1D-4F82-906A-226373BEEE8D
wdt:P433
3
wdt:P478
172
p:P356
wds:Q80450585-A5D99CFA-F692-4A04-BEB1-9E625709152C
wdtn:P356
n11:01.JU.0000136446.37840.0A
wdt:P356
10.1097/01.JU.0000136446.37840.0A